ReviewNaunyn-Schmiedeberg's archives of pharmacology2025

Flavopiridol: a promising cyclin-dependent kinase inhibitor in cancer treatment.

Uttam Singh Baghel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.